PCMA Statement on Trump Administration’s GLP-1 Announcement

(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement following the Trump Administration’s announcement on lowering prices on GLP-1 products. “America’s pharmacy benefit managers (PBMs) applaud the Trump Administration for continuing to hold Big Pharma accountable for the egregious prices they set on brand-name drugs in the United States, especially for […]